BOULDER, Colo. (AP) _ Nivalis Therapeutics Inc. (NVLS) on Monday reported a loss of $8.9 million in its first quarter.
The Boulder, Colorado-based company said it had a loss of 57 cents per share. Losses, adjusted for restructuring costs, were 35 cents per share.
In the final minutes of trading on Monday, the company's shares hit $2.25. A year ago, they were trading at $4.23.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVLS at https://www.zacks.com/ap/NVLS
Keywords: Nivalis Therapeutics, Earnings Report